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Abstract
The focal adhesion protein testin is a modular scaffold and tumour suppressor that consists
of an N-terminal cysteine rich (CR) domain, a PET domain of unknown function and three C-
terminal LIM domains. Testin has been proposed to have an open and a closed conforma-
tion based on the observation that its N-terminal half and C-terminal half directly interact.
Here we extend the testin conformational model by demonstrating that testin can also form
an antiparallel homodimer. In support of this extended model we determined that the testin
region (amino acids 52–233) harbouring the PET domain interacts with the C-terminal LIM1-
2 domains in vitro and in cells, and assign a critical role to tyrosine 288 in this interaction.
Introduction
Human testin (NP_056456.1), encoded by the TES gene (Unigene Hs.592286), is a modular
scaffold protein consisting of a cysteine rich (CR) region, a central PET (Prickle, Espinas, Tes-
tin) domain and three LIM (Linl-1, Isl-1, Mec-3) domains together constituting the C-terminal
half of testin (Fig 1A) [1–3]. LIM domains contain two zinc-fingers and are known to be scaf-
folds for protein-protein interactions [4]. The interest in testin mainly arises from the fact
that it has been shown to be downregulated in an increasing number of human tumour types
where its downregulation correlates with disease progression [5–10]. In multiple studies in
mice and tumour cells, overexpression of testin leads to increased cell spreading and apoptosis,
inhibition of tumour cell proliferation and migration, or a reduction of tumour formation in
nude mice [1,9,11–13]. In addition, Tes knockout mice have an enhanced susceptibility to
develop drug-induced gastric carcinomas [14].
Although a role for testin in p38-signalling has been suggested [9], previous reports mainly
provide evidence that testin is a component of the actin cytoskeleton. It interacts with multiple
actin cytoskeletal proteins (zyxin, α-actinin, mammalian enabled (MENA), vasodilator stimu-
lated phosphoprotein (VASP), ena/VASP-like protein (Evl), spectrin, paxillin, talin and
transforming growth factor beta-1-induced transcript 1 (Hic-5) and is present in actin-rich
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structures such as stress fibres, integrin based-cell-substrate contacts (focal adhesions) and
cadherin-based cell-cell contacts (adherens junctions) [1,2,15–18]. We recently reported a pro-
teomics-based interactome study using the different testin domains as bait, detailing more
than 100 proteins newly identified as present in testin-containing co-complexes in a domain-
dependent manner [18]. This is consistent with the intriguing observation that the subcellular
localization of testin is different for the full length protein than for engineered parts of the pro-
tein. Indeed, the N-terminal half of testin and the C-terminal half, differentially localize to
stress fibres and focal adhesions, respectively, whereas the full length protein (FL) displays a
diffuse localization in the cytosol with only a small fraction enriched in actin-rich structures
[2,3,18,19]. To explain this, a conformational model was formulated a decade ago: testin is pro-
posed to be present in a closed and an open conformation [1]. The open testin form is sug-
gested to allow e.g. LIM-domain based recruitment to focal adhesions and interaction with
known focal adhesion components such as zyxin.
During the interactomics study of testin [18], we unexpectedly found that ectopically
expressed testin-variants and endogenous testin reside in one complex raising the possibility
that testin forms dimers. In the present study, we used purified recombinant testin to show
that it effectively exists in a monomeric and dimeric form. In addition, using experiments in
vitro and in cells, we show that the region 52–233 containing the PET domain directly interacts
with the LIM1-2 domains and contributes to the inter- or intramolecular interaction. This
assigns a function to the PET domain and its flanking regions as an additional protein interac-
tion module within testin. Because testin is capable of forming a monomer or a dimer, we
conclude that the conformational repertoire of testin is more extensive than the open/closed
monomeric transition previously described [1].
Results
Full length testin forms a dimer
In an extensive testin interactome study in HeLa cells we used a set of green fluorescent pro-
tein (GFP)-fused testin protein variants as bait to analyse, via affinity purification-mass spec-
trometry (AP-MS), the composition of the protein complexes these testin variants participate
in. This is extensively reported in [18]. Of interest here, testin peptides that could only origi-
nate from endogenous testin, were present in the tryptic digest of the co-precipitated com-
plexes using the ΔPET-GFP and the LIM1-3-GFP variant (Fig 1A) as bait. Indeed, as indicated
in Fig 1B, we identified three PET domain peptides in a complex with the testin variant lacking
the PET domain (ΔPET-GFP) and one peptide of the linker region between the PET and LIM1
domains in association with LIM1-3-GFP. In this AP-MS assay, recovery of testin peptides
from endogenous protein could either result from an indirect recruitment (i.e. via VASP or
zyxin or another unknown partner) or from a direct testin-testin intermolecular interaction.
We explored the latter possibility.
We first used an in vitro binding assay with purified components to determine whether full
length (FL) testin directly interacts with itself (scheme Fig 2A). We immobilized recombinant
glutathione-S-transferase GST-FL (Fig 1A), produced in E. coli, on glutathione–coupled
sepharose as bait and incubated this resin with non-tagged recombinant FL as prey (input (I)
in Fig 2B). The latter was obtained from GST-FL by exploiting a thrombin recognition site
present between the GST-tag and FL, followed by inactivation of thrombin (see Methods).
As negative control, we used GST coupled resin that was similarly incubated with soluble
untagged FL. The interaction between immobilized GST-FL and soluble FL was monitored by
western blot analysis of the proteins on the resin using anti-testin and anti-GST antibodies. Fig
2B shows that FL binds to the GST-FL on the resin (lane ‘GST-FL/P’) but not to the GST resin
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Fig 1. Tagged testin constructs. A) Scheme of the structural domains of testin and of the different modular testin
variants used in this study. Testin variants are coupled to GFP, GST or myc/mito (see Methods for details, ‘+’ indicates
that a particular tagged version of the testin variant is used in one or more of the experiments presented in the
manuscript). CR: cysteine rich; PET: Prickle, Espinas, Testin; LIM: Linl-1, Isl-1, Mec-3, NT: N-terminal part. Numbers
indicate start and end of protein variants based on the numbering of full length (FL) human testin isoform 1 (Database
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(lane ‘GST/P’), indicating a direct testin-testin interaction. We also mock-incubated the
FL-GST-beads with buffer lacking soluble FL as prey but containing a similar amount of
thrombin that was inactivated in an identical manner. Under these conditions, untagged FL is
not present in the analysed resin (Fig 2C, lane ‘P’) and this excludes that the FL, identified as
bound to the GST-FL resin in Fig 2B (lane ‘GST-FL/P’), was a (residual thrombin) breakdown
product of GST-FL on the resin. We also incorporated an additional positive and negative con-
trol in the experimental setup (Fig 2D–2F). The GST-FL coupled resin retained the known tes-
tin partner Evl (Fig 2D, positive control) but not cofilin (Fig 2F, negative control). Together
these data demonstrate that purified FL is capable of forming a direct intermolecular interac-
tion in vitro.
This predicts that testin is capable of forming homomeric species. To demonstrate this, we
performed size exclusion chromatography (SEC) with recombinant untagged FL testin using a
calibrated column. A typical separation pattern and the analysis of selected fractions using
SDS-PAGE and Coomassie staining is shown in Fig 3 (top panel). Two testin containing peaks
(labelled a and b) eluted from the column. Based on the elution volumes measured at the maxi-
mum of the peaks and a molecular weight (MW) calibration curve (S1A Fig), we estimated the
MW of the two corresponding testin species. For proteins eluting in peak b (approx. elution
volume 13 ml), we derive a MW of ~60 kDa which is slightly higher than the calculated MW
of a testin monomer (47996 Da) (see Discussion). Similarly, we derive for peak a (eluting at
approx. 11 ml) a MW of ~ 98 kDa and this is close to the calculated MW of 95992 Da for a
dimeric testin form. To exclude that the presence of a dimer peak is due to oxidation of the
sample, we treated fractions 3 and 4 with sample buffer lacking the reducing agent dithiothrei-
tol followed by Coomassie analysis (S1B Fig). A monomeric testin signal (~50 kDa) was
detected and no higher molecular weight signal resulting from an oxidation of the protein was
visible. These results are therefore most consistent with the presence of a monomeric and a
dimeric testin population. Fractions 3 and 4 representing the main part of the dimer peak (a)
were pooled and subjected to a second SEC on the same column. Fig 3 (bottom left) shows this
results in the formation of a new monomer population in the time in between the two SEC
runs. In addition, we pooled the tail fractions 7 and 8 of the monomer peak (b) from the first
SEC, concentrated and reanalysed them by SEC. The chromatogram in Fig 3 (bottom right)
shows the presence of a new dimer population formed from the original monomeric pool.
Together this demonstrates a dynamic equilibrium between the monomer and dimer popula-
tion. Taking the results from the SEC experiments together with the binding data, we demon-
strate that testin is capable of dynamically forming a homodimer in vitro.
The PET containing region of testin directly interacts with LIM1-2
domains in vitro
Garvalov et al. [1] showed that the N-terminal half of testin (containing the CR and PET
domains) and the C-terminal half (containing the three LIM domains) directly interact. This
was interpreted in terms of an intramolecular interaction, however the parts of the molecule
mediating this interaction could also be at play in the dimer formation which we showed in
the previous section. Therefore, we set out to more finely delineate which regions in testin are
required for interacting with each other as this is relevant for dimer formation in addition to
ID: NP_056456.1). B) Sequence and location of testin peptides originating from endogenous testin that were identified
using a mass spectrometry-based approach in the tryptic digests of complexes affinity purified using a GFP-nanobody
from lysates of HeLa cells expressing ΔPET-GFP or LIM1-3-GFP as bait (PRIDE dataset identifier: PXD005058)
[18,20].
https://doi.org/10.1371/journal.pone.0177879.g001
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Fig 2. Full length testin interacts with full length testin in vitro. A) General Scheme of affinity purification used to produce data
in several figures, to demonstrate an interaction of testin with other testin variants. In panel B of this figure, recombinant GST-FL
was either used as bait on glutathione-sepharose or in parallel treated with thrombin to remove GST to be used as prey in an
untagged form. Thrombin was inactivated prior to addition of this soluble form (input: I) to the resin with GST bound protein. After
washing the resin, bound proteins were eluted with heated sample buffer and thus contain both bait and potential prey proteins
Expanding the conformational model of testin
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the possible intramolecular interactions. Additionally, it may allow defining whether the
dimer is formed in a parallel or antiparallel manner.
We applied an affinity pull down approach similar to the one shown in the scheme in Fig
2A, again using E. coli produced fragments of testin. One testin variant as bait was immobilised
on the resin via its GST-tag and incubated with a purified untagged testin variant as prey in
solution. Starting from the observation that the three C-terminal LIM domains interact with
the N-terminal half (Garvalov et al., [1]), we first assessed which region of the N-terminal half
of testin is responsible for the interaction with LIM1-3: CR or the region including the PET
domain (residues 92–199, www.ebi.ac.uk/interpro/entry/IPR033724), here named PET52-233
(see Fig 1A). We tested the potential interactions of recombinant immobilised GST-CR with
LIM-1-3 or, alternatively, GST-LIM-1-3 with PET52-233 (Fig 4A and 4B respectively, see Fig 1A
for used variants). We used GST-cofilin resin as a negative control. After elution and SDS-
PAGE the potential interactions were monitored by Coomassie staining. Fig 4A illustrates that
there is no direct interaction between LIM-1-3 and CR. In contrast, Fig 4B shows a direct
interaction between PET52-233 and the immobilised LIM1-3 domains (red box, Fig 4B). These
in vitro data demonstrate that the PET52-233 region possesses the interaction information
within NT. In a similar way, we assessed whether LIM1-3 could be retained on a GST-LIM1-3
resin (Fig 4C), which was not the case, illustrating that the observed signal in Fig 4B originates
from PET52-233 and not from breakdown of the GST-LIM1-3 on the resin. To additionally vali-
date the role of the region harbouring the PET domain for an intra- and/or intermolecular tes-
tin interaction, we used a testin variant lacking the PET domain (deletion of residues 92–199).
Fig 4D shows that ΔPET (prey) and immobilised GST-ΔPET (bait) indeed do not interact
despite the presence of the LIM domains.
We performed a supernatans depletion assay [21] to determine the affinity of the PET52-233
LIM1-3 interaction. We incubated different concentrations of GST-LIM1-3, coupled to gluta-
thione-sepharose beads, with 2.5 μM of PET52-233 and measured its depletion from the super-
natans on Coomassie stained gels (Fig 4E). From the intensities on gel, we calculated the
bound PET52-233 fractions and plotted these versus the LIM1-3 concentrations. Beads lacking
GST-LIM1-3 were similarly incubated with 2.5 μM of PET52-233 to assess aspecific binding.
This revealed that measurable non-specific binding of PET52-233 to the beads occurred. We
therefore took this in account in the model for fitting (see Materials and methods section
for details). This allowed determining a dissociation equilibrium constant (Kd) for the interac-
tion between isolated PET52-233 and LIM1-3 domains which is within the nanomolar range
(Kd = 0,18 μM ± 0,06).
We further tried narrowing down the interaction sites. A GST-testin variant containing only
LIM domains 1 and 2, used as bait, is sufficient for the interaction with PET52-233 (Figs 1A and
5A). Additional experiments in HeLa cells with LIM2-3, LIMΔ2 (a testin variant containing
LIM domain 1 fused to 3, Fig 1A) as well as the individual LIM1 and LIM2 domains provide no
(affinity purified: P). Proteins were detected either by Western Blotting (Figs 2B–2F and 4D) or Coomassie (Figs 4A–4C and 5A–
5D), T = temperature. B) Immobilised recombinant GST-FL (bait) was incubated with soluble recombinant untagged FL (prey). A
Western blot using anti-testin (green) and anti-GST (red) antibodies of the input (I) and proteins on the resin (P) is shown. FL prey
(approx. 50 kDa) was present on the resin together with the bait GST-FL (lane ‘GST-FL/P’). Input (I) shows the untagged FL in
solution. Recombinant immobilised GST was used as a negative control (lane ‘GST/P’). C) Western blot analysis (anti-testin
(green), anti-GST (red)) of a mock buffer control incubated with immobilised GST-FL on resin. Similar as in B, the buffer contains
inactivated thrombin but no soluble FL prey. Untagged FL is absent on the resin (P) (compare to Fig 2B, lane ‘GST-FL/P’) indicating
that possible residual thrombin activity is not cleaving the GST-FL on the resin. D, E, F) Immobilised recombinant GST-FL (bait) was
incubated with soluble untagged Evl (positive control, D) or cofilin (negative control, F) as preys. Immobilised GST was incubated
with Evl (prey) and used as additional negative control (E). Western blot analysis of inputs (I) and proteins on the resin (P) is shown
using anti testin (green), anti-Evl, anti-cofilin and anti-GST (red) antibodies. Untagged Evl (prey) is present on the GST-FL resin
(lane P, 2D). Positions of bait, prey and negative control bait (Neg Ctr) are indicated in each panel. M: marker proteins (kDa).
https://doi.org/10.1371/journal.pone.0177879.g002
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evidence for interaction with PET52-233 suggesting that both the first and second LIM domains
are necessary to ensure this interaction (S4B–S4E Fig and Discussion). In addition to PET52-233,
we constructed three truncated variants covering only the PET domain (PET92-199) or the PET
domain flanked by one of the two linker regions (PET52-199 and PET92-233) (Fig 1A). These
truncated PET variants as well as the PET52-233 variant were used as prey to assess potential
interactions with the immobilized LIM1-2 baits. Unlike PET52-233 which interacted with the
LIM1-2 bait (lane P1 in Fig 5A), neither of the three truncated PET variants was retained by the
Fig 3. Size exclusion chromatography reveals dimer formation of testin in vitro. Top panel:
Chromatogram of SEC of purified recombinant FL. Absorbance (280 nm) is plotted versus elution volume
(ml). Two elution peaks are present (labelled a and b). Bold numbers 1–9 on top of chromatogram indicate the
collected fractions which all contain testin as visualized by Coomassie staining after SDS-PAGE (see S1A Fig
for column calibration). Bottom panels: Re-analysis by SEC of pooled fractions 3 and 4 (bottom left) or 7 and 8
(bottom right) of the primary SEC (boxed in top panel). Fractions 7 and 8 were first pooled and concentrated to
a final concentration of 3,1 mg/ml prior to re-analysis with SEC. In both secondary runs two peaks eluted
corresponding to dimeric (a) and monomeric (b) testin evidencing that both forms are in dynamic equilibrium
with each other.
https://doi.org/10.1371/journal.pone.0177879.g003
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Fig 4. PET52-233 of testin directly interacts with LIM1-3 domains in vitro. A-D) The experimental setup is similar as
shown in Fig 2A. A recombinant GST-testin variant used as bait (GST-CR (A), GST-LIM1-3 (B, C) or GST-ΔPET (D)) was
trapped on glutathione resin and presented in immobilised form to a second untagged testin-variant in solution used as prey
(LIM1-3 (A, C), PET52-233 (B) or ΔPET (D)). Coomassie stained SDS-PAGE analysis (A-C) or western blot analysis (D)
using anti-testin (green) and anti-GST (red) antibodies is shown. Input (I) shows the untagged prey protein prior to
Expanding the conformational model of testin
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incubation with the resin. Lanes indicated with P show the proteins present on the resin (immobilized bait and/or bound
prey) after the incubation. GST resin (D) or GST-cofilin resin (A-C) incubated with the same untagged testin variant as prey
were used as negative controls. Untagged protein bound to the GST-testin variant immobilised on the resin is highlighted by
a red box (B). Positions of bait, prey and negative control (Neg Ctr) bait are indicated in each panel, M: marker proteins
(kDa). E) The indicated concentrations of GST-LIM1-3 immobilized on glutathione-sepharose beads were prepared and
incubated with 2.5μM PET52-233. For each LIM1-3 concentration (indicated as [GST-LIM1-3]total (μM)), the level of unbound
PET52-233 was analysed by Coomassie staining after SDS-PAGE (left). Aspecific binding was assessed by incubation of
glutathione-sepharose beads, lacking LIM1-3, with a similar concentration of PET52-233 I: input, representing 2.5 μM
PET52-233 in solution without incubation to LIM-1-3 coupled glutathione beads (reference for unbound 100% or bound 0%),
A: aspecific binding of the PET52-233 ligand to beads without LIM1-3, M: molecular weight marker (kDa). (right) The %
amounts of bound PET52-233 calculated from the measured intensities of the unbound material on gel (left) were plotted
versus GST-LIM1-3 concentrations (graph right, red dots). The amount of aspecifically bound PET52-233 is represented by a
black dot. The solid blue line in the graph is the fitted curve taking into account aspecific binding (see Materials and methods
for details).
https://doi.org/10.1371/journal.pone.0177879.g004
Fig 5. The PET domain of testin is not sufficient for interaction with LIM1-2 domains in vitro. The experimental setup is
similar as the scheme in Fig 2A. Immobilised GST-LIM1-2 on glutathione resin was incubated with untagged PET52-233(A),
PET92-199(B), PET52-199 (C) or PET92-233 (D) in solution, used as preys. Coomassie stained SDS-PAGE analysis is shown: input (I)
shows the untagged prey protein prior to incubation with the resin. Lanes indicated with P1 show the proteins present on the resin.
We here included an extra negative control: the immobilised baits on the resin were mock-incubated with a solution lacking the
soluble preys as in some cases the bait construct is prone to degradation during immobilization on the resin (lanes labelled P2).
GST-cofilin resin was used as second negative control in each setup (lanes P3). Untagged prey protein PET52-233 bound to the
GST- LIM1-2 testin variant immobilised on the resin is highlighted by a red box (A). Positions of bait, prey and negative control
(Neg Ctr) bait are indicated in each panel, M: marker proteins (kDa).
https://doi.org/10.1371/journal.pone.0177879.g005
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LIM 1–2 bait (lanes labelled P1 in Fig 5B–5D) demonstrating that the PET92-199 domain and its
flanking linker regions are necessary to ensure a detectable interaction with the LIM domains
under the tested conditions. In a similar way, we found that the three truncated PET variants
were not retained by a LIM1-3 bait excluding that a weak contribution to the interaction was
due to the third LIM domain (S2B–S2D Fig). This lack of interaction between the isolated
PET92-199 domain and LIM1-2 could be caused by loss of its folded conformation upon elimi-
nating the flanking regions of the PET domain. We therefore performed circular dichroism
(CD) measurements on both variants (S3 Fig). Although the spectra are different they reveal
that both PET52-233 and PET92-199 are structured and likely dominated by α-helices (consistent
with findings for the Drosophila prickle PET domain, [22]). Thus, unfolding of the PET
domain cannot be the cause of its lack of binding to LIM1-2 in the context of 92–199, 52–199
or 92–233.
Taken together, these data establish that the PET domain and its flanking regions interact
with nanomolar affinity with the LIM1-2 domains and strongly suggests that, using this inter-
action, testin adopts either a monomeric conformation or exists as an antiparallel homodimer.
The region 52–233 containing the PET domain interacts with the testin
LIM1-2 domains in a cellular context
We set out to validate the interaction between PET52-233 and LIM1-2 in HeLa cells using an in
cellulo recruitment assay with myc/mito tagged testin variants. The mito tag was originally
identified as the mitochondrial targeting domain of the ActA proteins of the bacteria Listeria
monocytogenesis [23], and subsequently successfully used to artificially target the mito-tagged
fusion proteins together with their interaction partners in cells to the mitochondrial surface
[16,24]. The expressed myc-mito tagged testin variants served as intracellular baits for ectopic
recruitment of preys. The myc-tag was used for bait detection. A GFP tagged testin variant
is co-transfected as prey and co-localisation of the latter at the mitochondria with the mito
tagged bait is indicative of an interaction of both variants in a cellular context. Fig 6A demon-
strates that, in HeLa cells, LIM1-3-GFP (Fig 1A) colocalizes with NT-myc/mito. Similarly,
LIM1-3-GFP was also recruited by PET52-233-myc/mito (Fig 6B) as was LIM1-2-GFP (Fig 6C).
As expected based on the in vitro data, ΔPET myc/mito, lacking the PET92-199 domain, did not
recruit LIM-1-2-GFP (Fig 6D). The latter result also indicates it is unlikely that the recruitment
of the LIM domains observed above was indirect via the scaffolding interaction of the LIM
domains. This illustrates that the region 52–233 containing the PET domain and LIM1-2 are
essential for an intermolecular testin interaction in a cellular context.
Y288 is (structurally) important for the testin-testin interaction
The in vitro and in cellulo demonstrated interaction between PET52-233 and LIM1-2, may sup-
port conformational regulation of testin by allowing an intra- and/or intermolecular testin
interaction in cells. The atomic 3D structure of the PET domain is still unknown, but the struc-
ture of LIM2-3 in complex with the partner proteins Mena and Arp7A (actin related protein
7A) has been derived [3] (Database id: 2xqn). Fig 7A shows the alignment of the three LIM
domain sequences of testin demonstrating that LIM1 tyrosine 288 aligns to LIM2 valine 348.
The latter residue makes an important stacking interaction between the LIM2 and LIM3
domains (derived from visual inspection of structure 2xqn [3]). We hypothesized that the
LIM1 residue Y288 may have a similar role in a stacking interaction between LIM1 and LIM2
and thus that Y288 may determine the relative orientation of LIM1 and LIM2. We mutated
Y288 to alanine in the full length testin context (Fig 1A). This substitution did not impair testin
localization to focal adhesions in HeLa cells (Fig 7B). GST-FLY288A mutant or GST-FL on
Expanding the conformational model of testin
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Fig 6. The region 52–233 containing the PET domain of testin directly interacts with LIM1-2 domains in cells. Immunofluorescence
staining of myc/mito-coupled (bait) and GFP-coupled (prey) testin constructs in HeLa cells. Myc signal (red), GFP signal (green) and merge are
shown for each condition. Colocalisation is observed for NT-myc/mito and LIM1-3-GFP (A), PET52-233-myc/mito and LIM1-3-GFP (B) and
PET52-233-myc/mito and LIM1-2-GFP (C). Absence of colocalisation is observed for ΔPETΔ92-199-myc/mito and LIM1-2-GFP (D). See also S4
Fig.
https://doi.org/10.1371/journal.pone.0177879.g006
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Fig 7. Y288 is important for testin-testin interaction. A) Multiple sequence alignment of the LIM domains of testin.
Zinc coordinating cysteines (C) and histidines (H) are indicated with yellow highlight. Tyrosine (Y) 288 and valine (V)
348 are indicated in red and green respectively. This valine in LIM2 makes a hydrophobic stacking interaction with
LIM3 based on the crystal structure in (Database id: 2xqn, [3]) B) Localization of GFP-coupled FL and FL-Y288A
constructs in fixed HeLa cells. The GFP and vinculin signals are shown. FL and Y288A are distributed throughout the
cytosol and present in focal adhesions. C) Immobilised recombinant GST -FL or GST-FL-Y288A (bait) was incubated
with a similar amount of soluble recombinant untagged FL (prey) followed by western blot analysis of the protein on
the resin using anti-testin (green) and anti-GST (red) antibodies. FL (approx. 50 kDa) is present on the resin (P)
together with the immobilised GST-FL and immobilised GST-FL-Y288A. Input (I) shows the untagged FL prey in
solution. Note the strongly reduced amount of bound FL when FL-Y288A mutant is used as bait. Positions of bait and
prey are indicated in each panel. Molecular weights (kDa) are indicated.
https://doi.org/10.1371/journal.pone.0177879.g007
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resin (baits) were, in parallel, incubated with equal amounts of FL (prey) to compare their
capacity to form a dimer in vitro. Fig 7C demonstrates that both interactions take place (see
‘P’), but the affinity of FL for the mutant is strongly reduced. These data suggest that Y288
between the LIM1 and LIM2 domains is of structural importance for the interaction with
PET52-233.
Discussion
In this study, we demonstrated that the focal adhesion protein testin exists, in addition to its
monomeric form, as an antiparallel (or head to tail) homodimer. This is not unprecedented
for focal adhesion proteins since vinculin and talin are also capable of self-associating either
into homodimeric protein complexes or (closed) monomeric species [25–27]. Similarly, the
Ezrin/radixin/moesin (ERM) family members, proteins connecting the actin cytoskeleton to
the plasma membrane, are also capable of forming closed monomers and/or anti-parallel
dimers through a direct interaction between their N- and C-termini [28]. The dimeric and
monomeric forms of purified testin were observed in equilibrium in sequential size exclusion
chromatography experiments. The estimated molecular weight of 60 kDa of the monomeric
form which we obtained by SEC analysis deviates from the predicted one (approximately 48
kDa). This higher estimation may indicate that this form has an elongated structure resulting
in a higher apparent molecular volume than expected. A similar observation has been previ-
ously made for other LIM domain containing proteins [see e.g. 29]. For the dimer, the esti-
mated MW (98 kDa) deviates less, which suggests that this conformational state is becoming
more spherical reducing its molecular volume.
We determined an affinity in the nanomolar range between PET52-233 within the N-termi-
nal half of testin and LIM1-3. We further demonstrated that LIM1-2 form the major interac-
tion site in the C-terminal half. The PET domain was originally found as part of the Drosophila
prickle and espinas proteins. These proteins also contain three C-terminal LIM domains and
are shown to play an important role in the planar cell polarity process [22]. Hitherto the func-
tionality of the PET domain of testin was little investigated. In an interactomics study we
recently showed that the testing PET52-233 region is a protein-protein interaction module [18].
Membrane binding has been suggested for Drosophila Prickle PET [30] and, interestingly, in
that paper the three LIM domains of Prickle increased the stability of the PET domain. This is
also in agreement with the physical interaction between these domains observed here. Here we
propose an additional role for PET52-233 in regulating the conformation of testin by interacting
with the first two LIM domains, enabling either an intramolecular or intermolecular interac-
tion, the latter resulting in dimer formation. Interestingly, the PET domain was not sufficient
to mediate this interaction. This is evidenced by lack of direct interaction of the isolated PET
domain (residues 92–199) with LIM1-2 (or LIM1-3) as well as by the failure of dimer forma-
tion of the ΔPET variants. This also assigns a role to the regions adjacent to the PET domain;
they appear to contain binding information. Interestingly, part of these linker regions between
either the cysteine rich region and the PET domain or the PET domain and the LIM domains
are predicted as intrinsically disordered regions by PrDOS (http://prdos.hgc.jp/cgi-bin/top.
cgi). Collectively this indicates that the sequence information within PET52-233 that are
required for binding LIM1-2 do not constitute a simple linear recognition motif. Both LIM1
and LIM2 domains are required for high affinity interaction since in a cellular context the
PET52-233 region does not interact with the separate LIM1 or LIM2 domains, nor with the
third LIM domain (LIM3) or the last two LIM domains (LIM2-3) (S4B–S4F Fig). This dis-
agrees with a previous finding that demonstrated that the N-terminal half of testin directly
interacts with the third LIM domain and not with LIM1-2 in vitro [31]. Different purification
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conditions (native, this work; denaturing and renaturing from inclusion bodies [31]) may be a
possible explanation for this discrepancy. Our data are confirmed in mammalian cells and a
further proof that the LIM1-2 domains are involved comes from our observation that mutating
the LIM1 residue Y288 strongly diminishes dimer formation. This mutant still localizes to
focal adhesions in cells, supporting its functionality (Fig 7B). The observed lack of dimer for-
mation for FL-Y288 suggests that Y288 is an interface residue between the PET and LIM1-2
modules. Alternatively, this raises the possibility that introducing the mutation alters the
orientation of the involved LIM domains relative to each other. This and whether Y288 is
involved in opening the testin molecule is, however subject to future investigations.
Garvalov and coworkers have previously proposed that testin adopts an open or closed
monomeric conformation, of which the latter can be formed by a direct interaction between
its N-terminal and C-terminal halves[1]. This interaction however does not necessarily contra-
dict the dimer formation we observed here. We accordingly extend the existing conforma-
tional model (Fig 8). Our finding that the PET52-233 region directly interacts with the C-
Fig 8. Conformational model of the testin protein. Testin can adopt an open active monomeric or a closed inactive monomeric conformation (as
proposed by Garvalov et al. [1]) or an antiparallel dimeric conformation (this work). The activity status of the dimer is unknown (see Discussion). The
interaction between PET52-233 and the LIM1-2 domains underlies formation of the dimer and/or closed monomer conformation.
https://doi.org/10.1371/journal.pone.0177879.g008
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terminal LIM1-2 domains and that this mediates the intra- and intermolecular testin interac-
tions requires revising the previous conformational model of testin [1].
In Fig 8 we propose the existence of three and not two conformational states of the testin
protein being a closed monomer, an open monomer and an antiparallel dimeric state. This
may present another example of a 3D-domain-swapped system of a monomer and homodimer
as observed for diphtheria toxin, and calcium and integrin binding protein [32,33]. At present,
it is however unclear whether the dimer is an inactive form, similar to the closed monomer
wherein specific domains or protein-protein interaction interfaces are inaccessible, or an
active form. We indeed recently showed that the interactome of the full length protein is differ-
ent from those of testin variants that only contain specific domains [18]. The mechanism that
drives the conformational transitions between the closed monomer and the dimer in testin
remains to be investigated but the open monomeric conformation could be a logical interme-
diate. In cells, these transitions are likely subject to regulation, which can involve either the
PET- or the LIM1-2 domains or both. One scenario is that an interaction of testin with one of
its partner proteins favours the (intermediate) open monomeric conformation ([1], thebio-
grid.org/117572, [18]). Another attractive possibility is that the LIM1 domain becomes phos-
phorylated because this domain is a hotspot for phosphorylation events (Database ID: TES
(human)). It is also important to note that, although most activities of testin that have been
described so far are usually linked to testin at focal adhesions, testin has also been observed in
the nucleolus [31] and in adherens junctions [17]. Testin may thus display additional specific
cellular functionalities in which monomeric or homodimeric species have differential proper-
ties. The new model (Fig 8) may consequently form a more realistic basis to investigate the
role of testin in cells, in particular in cancer cells.
Materials and methods
Testin encoding expression vectors
Testin variants (see Fig 1A) were expressed as recombinant GST-fusion proteins using pGEX-
2TK (GE Healthcare) vectors in which the cDNAs encoding human FL (full length protein),
PET52-233 (amino acids 52–233), PET52-199 (amino acids 52–199), PET92-233 (amino acids 92–
233), PET92-199 (amino acids 92–199) or ΔPET (amino acids 1–91 fused to 200–421, i.e. dele-
tion of PET domain) were cloned using the BamHI and SmaI restriction sites in the multiple
cloning site. For the GST-LIM1-3 construct, the FL-pGEX-2TK plasmid was digested with
NcoI, eliminating the N-terminal CR and PET domains from the plasmid. The cDNAs encod-
ing CR (CR domain) or FL-Y288A (Y288A substitution, FL here coupled to HIS tag) were
cloned using the BamHI and SalI restriction sites in the multiple cloning site of pGEX-4T-2
(GE Healthcare). The cDNA encoding LIM1-2 (first 2 LIM domains, here coupled to a HIS
tag) was cloned using EcoRI and SalI restriction sites in pGEX-4T-2. All GST-fusion proteins
carry a thrombin cleavage site allowing removal of the GST tag. The GST-cofilin construct
has been described in [34]. For mammalian expression as eGFP-fusion proteins, FL-GFP
was generated by cloning the cDNA corresponding to the full length protein (residues1–421)
into the pEGFP-N3 vector (Clontech) [16]. For FL-Y288A, the construct was cloned into the
pEGFP-N3 vector by DNA2.0. The cDNAs encoding LIM1-3, LIM1-2, LIM2-3, LIMΔ2,
LIM1, LIM2 or LIM3 were cloned using the XhoI and BamHI restriction sites in the multiple
cloning site of pEGFP-C3 (Clontech) (Fig 1A). The cDNAs encoding NT or ΔPET were cloned
using the SacII and SphI restriction sites, and the cDNA encoding PET52-233 was cloned using
NotI and SalI in the multiple cloning site of a pUHD10.3 vector encoding as tag a myc tag
combined with the carboxy-terminal amino acids of ActA [23,24]. The latter is termed ‘mito
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tag’ as it allows targeting proteins to the mitochondrial surface [23]. All constructs were veri-
fied by sequencing.
Cell culture and transfection
HeLa cells were cultured in Dulbecco’s Modified Eagle Medium with Glutamax supplemented
with 10% fetal bovine serum and 1% penicillin/streptomycin (Gibco, Life Technologies) at
37˚C and 5% CO2. Cells in a 6 well plate on coverslips (1.2x10
5 cells/well) were transfected
with 5 μg of one of the above described plasmids using calcium phosphate transfection.
Recombinant GST-testin (variant) production and purification
The empty pGEX-2TK or pGEX-4T-2 vectors or those encoding a GST-testin variant were
transformed in the E. coli BL21(DE3) pLYSstar strain. Bacteria were pre-cultured at 37˚C for 4
h in Luria Bertani (LB) medium supplemented with 1% glucose. This pre-culture was diluted
(1/25) in LB medium and grown at 37˚C until an optical density of 0.6. Recombinant protein
expression was induced by isopropyl-β-D-thiogalactopyranoside (1 mM) in LB medium that
was supplemented with 10 μM zinc-acetate and grown at 16˚C overnight. Bacterial cells were
lysed in 25 mM Hepes (pH 7.6), 0.1 mM EDTA, 5 mM dithiothreitol, complete protease inhib-
itor cocktail (Roche) and 10.000 units/ml lysozyme (Amersham) and sonicated for 5 min on
ice. GST or the GST-fusion protein was purified from the clarified lysate (from a 25 ml cell cul-
ture) by incubation for 2 h at 4˚C with 25 μl glutathione sepharose™ 4B (GE Healthcare) in
buffer A (25 mM Hepes (pH 7.6), 150 mM NaCl, complete protease inhibitor cocktail). After
extensive washing in buffer A, the resin was used in the binding assay. See also scheme Fig 2A.
In vitro binding assay and detection
To cleave GST from a testin variant, the GST-testin variant coupled to glutathione resin was
treated for 15 min at 22˚C with 100 units/ml thrombin (Sigma) in buffer A with omission of
protease inhibitors. The cleaved, non-tagged testin variant was enriched in the flow through
and the co-eluting thrombin was inactivated by adding complete protease inhibitor cocktail
and 1 mM benzamidine (Sigma). To analyse binding between two testin variants, 5 μg of a
thus obtained non-tagged testin variant, used as prey, was incubated for 2 h at 4˚C in buffer A
with glutathione sepharose resin (25 μl) to which a specified GST-testin variant, used as bait.
Beads loaded with GST were used as negative control (see also Fig 2A). After incubation, the
beads were washed three times in buffer A at 4˚C, resuspended in sample buffer (65 mM Tris
HCl (pH 6.8), 5% SDS, 250 mM dithiothreitol, 20% glycerol and 0.2% bromophenol blue) and
heated to 95˚C for 5 min prior to SDS-PAGE analysis on 10% gels. The proteins retained on
the resin (the GST-tagged bait and its possible binding partner) where detected by Coomassie
staining or performing western blotting. For western blotting, after transfer, the membranes
(Whatman Protran nitrocellulose (Sigma)) were blocked for 1 h at room temperature in
Odyssey blocking buffer (Li-Cor) and incubated overnight at 4˚C with a primary antibody in
Odyssey blocking buffer. Membranes were washed three times in PBS, 0.1% Tween 20 (Sigma)
and incubated for 1 h at room temperature with a secondary antibody in Odyssey blocking
buffer. After 3 washes in PBS, 0.1% Tween 20 and one in MilliQ-H2O, signals were detected
on an Odyssey infrared imaging device (Li-Cor Biosciences). The mouse anti-testin antibody
(ab57292, Abcam), rabbit anti-GST antibody (ab9085, Abcam), rabbit anti-Evl ([35]) or rabbit
anti-cofilin (ACLF02, Cytoskeleton) were used at a 1/1000 dilution. The secondary goat anti-
mouse IRdye800 or goat anti-rabbit IRdye680 antibodies (Li-Cor Biosciences) were used at
1/10000.
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Size exclusion chromatography
Recombinant FL was produced and purified as described above and subsequently dialysed
overnight at 4˚C in buffer A. Untagged FL protein (1.5 mg or as specified) was loaded on a
Superdex ™ 200 HR 10/30 (GE Healthcare) column in a volume of 200 μl and separated at a
flow rate of 0.8 ml/min on an AKTA system (GE Healthcare). Fractions (500 μl) were collected
and analysed by SDS-PAGE. Where needed, samples were concentrated using Microcon-
10kDa Centrifugal Filter Units (Millipore). The column was calibrated under identical condi-
tions using a mixture of five standard proteins (Amersham): chymotrypsin (25 kDa), ovalbu-
min (45 kDa), albumin (68 kDa), aldolase (158 kDa) and catalase (240 kDa).
Supernatans depletion assay
The affinity of the PET52-233 -LIM1-3 interaction was determined according to the supernatans
depletion assay as recommended by Pollard [21]. Both proteins were produced and purified as
described above. We prepared a batch of GST-LIM1-3 on glutathione beads and diluted these
so that the final concentration of GST-LIM1-3 was 0,31; 0,63; 1,25; 2,50; 5; 10; 20; 30; 40 and
50 μM (the concentration indicated is based on the known amount of protein immobilized
and the total volume of the incubation mixture). Each condition was incubated with 2.5 μM
PET52-233 in buffer A for 1 hour at 4˚C. In a negative control reaction, aspecific binding
was assessed by incubation of the highest amount of glutathione-sepharose beads, without
GST-LIM1-3, with a similar amount of PET52-233. Beads were spinned down by centrifugation.
Identical volumes of the supernatans containing PET52-233 were analysed by SDS-PAGE fol-
lowed by Coomassie staining. The unbound PET52-233 intensities were quantified using the
Image Studio Lite software version 5.2 from Li-Cor and expressed as a % of the signal in the
control sample (2.5 μM PET52-233 not incubated with beads, i.e. no binding, 100% unbound).
Based hereupon, the % of bound PET52-233 was calculated for each condition and plotted versus
the used GST-LIM1-3 concentrations. Curve fitting and subsequent calculation of the equilib-
rium dissociation constant (Kd) was done in SigmaPlot13. We used the ‘one site saturation
+ nonspecific’ fitting setting because a considerable amount of aspecifical PET52-233 binding to
beads was evident from the negative control reaction (2.5 μM PET52-233 incubated with beads
lacking GST-LIM1-3). The fitting equation used in Sigmaplot is y = (x).Bmax / (Kd + (x)) + (x).
Ns with x: the GST-LIM1-3 concentration, y: the bound fraction of PET52-233, Bmax: maximal
PET52-233 binding, Kd: equilibrium dissociation constant and Ns: the portion of aspecific
binding.
Circular dichroism
Samples containg untagged testin variants were produced and purified as described above and
dialysed overnight at 4˚C in 10 mM NaH2PO4 pH 8. Measurements were performed with a
scan resolution of 0,5 nm and 15 spectra were accumulated per sample using a J-710 Jasco
spectropolarimeter. Buffer values were subtracted, curves were smoothened with the moving
average method and the molar ellipticity was calculated using the J-710 Jasco software version
1.11.01.
Immunofluorescent staining and microscopy
For microscopy experiments, the myc/mito tagged testin variants and GFP tagged testin vari-
ants were co-expressed in HeLa cells. Immunofluorescent staining was performed after fixa-
tion of the cells. The myc/mito tagged testin variants were detected using a primary mouse
anti-c-myc antibody (9E10, Millipore), and a secondary Alexa Fluor1 594 conjugated goat
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anti-mouse antibody (Invitrogen). Cells were imaged using a Zeiss LSM 510 Meta laser scan-
ning confocal microscope (Carl Zeiss, Jena, Germany) with a Plan-Apochromat 63x/1.40 Oil
DIC M27 objective. Images were processed using ZEN 2009 software. To monitor the subcel-
lular localisation of FL-GFP and FL-Y288-GFP, constructs were overexpressed in HeLa cells,
fixed and co-stained with a primary mouse anti-vinculin antibody (SIGMA) and a secondary
Goat anti-mouse Alexa 594 antibody. Cells were visualised using an epifluorescence micro-
scope (Leica DMRX, HCX PL APO 100x/1.35NA oil immersion lens).
Alignments
Alignment of the LIM domains was performed using the tool at multalin (http://multalin.
toulouse.inra.fr/multalin/).
Supporting information
S1 Fig. Size exclusion chromatography calibration curve and DTT treatment of dimeric
testin fractions. A) SEC calibration curve (log molecular weight is plotted versus elution vol-
ume (ml)) obtained using five proteins of which molecular weight and elution volume are dis-
played in the chart. Red and green dots show the elution volume of monomeric and dimeric
testin, respectively, and correspond to an estimated molecular weight of approximately 60 kDa
and 98 kDa respectively. B) Coomassie stained SDS-PAGE analysis of collected dimeric testin
fractions obtained after SEC analyses (see also Fig 3 top panel). Samples were treated either
without (1–3) or with the reducing agent DTT (250 mM) (4–6). 5μg (1 and 4), 10μg (2 and 5)
and 20 μg (3 and 6) of protein was loaded for analysis. Only a monomeric testin signal (~50
kDa) was detected for the non-treated conditions (1–3) indicating the absence of a dimeric
oxidation product. M: marker proteins (kDa).
(TIF)
S2 Fig. The PET domain of testin is not sufficient for interaction with LIM1-3 domains
in vitro. The experimental setup is similar as the scheme in Figs 2A and 4. Immobilised
GST-LIM1-3 on glutathione resin was incubated with untagged PET52-233(A), PET92-199(B),
PET52-199 (C) or PET92-233 (D) in solution, used as preys. Coomassie stained SDS-PAGE analy-
sis is shown: input (I) shows the untagged prey protein prior to incubation with the resin.
Lanes indicated with P1 show the proteins present on the resin. An extra negative control was
incorporated: the immobilised baits on the resin were mock-incubated with a solution lacking
the soluble preys because the used bait constructs is sometimes prone to degradation during
immobilization on the resin (lanes labelled P2). GST-cofilin resin was used as second negative
control in each setup (lanes P3). Untagged protein bound to the GST-testin variant immobi-
lised on the resin is highlighted by a red box (A). Positions of bait, prey and negative control
(Neg Ctr) bait are indicated in each panel, M: marker proteins (kDa).
(TIF)
S3 Fig. Circular dichroism of PET52-233 and PET92-199. CD spectra of PET52-233 (blue) and
PET92-199 (red). Molar ellipticity [deg cm2 dmol-1] is plotted versus wavelength (nm). Spectra
of PET52-233 and PET92-199 evidence these fragments of testin are structured.
(TIF)
S4 Fig. Interaction between PET52-233 and LIM1-2 in cells requires both LIM1 and LIM2
domains. Immunofluorescent staining of myc/mito-tagged (bait) and GFP-tagged (prey)
testin constructs in HeLa cells. Myc signal (red), GFP signal (green) are shown for each condi-
tion. PET52-233 myc/mito was used as bait (A-F). Note the dotted appearance of the (red)
bait signal consistent with targeting to the mitochondria via the mito-tag. When used as prey,
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LIM1-2-GFP was recruited by PET52-233(A, see also Fig 6C). No recruitment is observed when
LIM2-3-GFP, LIMΔ2-GFP, LIM1-GFP, LIM2-GFP or LIM3-GFP were used as prey (B-F).
(TIF)
Author Contributions
Conceptualization: MVT CA.
Funding acquisition: ESR CA.
Investigation: SS MC EH.
Methodology: SS.
Project administration: CA MVT ESR.
Resources: SS MC.
Supervision: ESR.
Validation: SS ESR MVT CA.
Visualization: SS MC MVT.
Writing – original draft: SS MVT CA.
Writing – review & editing: EH ESR.
References
1. Garvalov BK, Higgins TE, Sutherland JD, Zettl M, Scaplehorn N, Ko¨cher T, et al. The conformational
state of Tes regulates its zyxin-dependent recruitment to focal adhesions. J Cell Biol. 2003; 161(1):33–
9. https://doi.org/10.1083/jcb.200211015 PMID: 12695497
2. Boe¨da B, Briggs DC, Higgins T, Garvalov BK, Fadden AJ, McDonald NQ, et al. Tes, a Specific Mena
Interacting Partner, Breaks the Rules for EVH1 Binding. Mol Cell. 2007; 28(6):1071–82. https://doi.org/
10.1016/j.molcel.2007.10.033 PMID: 18158903
3. Boe¨da B, Knowles PP, Briggs DC, Murray-Rust J, Soriano E, Garvalov BK, et al. Molecular recognition
of the Tes LIM2-3 domains by the actin-related protein Arp7A. J Biol Chem. 2011; 286(13):11543–54.
https://doi.org/10.1074/jbc.M110.171264 PMID: 21278383
4. Zheng Q, Zhao Y. The diverse biofunctions of LIM domain proteins: determined by subcellular localiza-
tion and protein-protein interaction. Biol Cell. 2007; 99(9):489–502. https://doi.org/10.1042/
BC20060126 PMID: 17696879
5. Ma H, Weng D, Chen Y, Huang W, Pan K, Wang H, et al. Extensive analysis of D7S486 in primary gas-
tric cancer supports TESTIN as a candidate tumor suppressor gene. Mol Cancer. 2010; 9(1):190.
6. Weeks RJ, Kees UR, Song S, Morison IM. Silencing of TESTIN by dense biallelic promoter methylation
is the most common molecular event in childhood acute lymphoblastic leukaemia. Mol Cancer. BioMed
Central Ltd; 2010; 9(1):163.
7. Zhu J, Li X, Kong X, Moran MS, Su P, Haffty BG, et al. Testin is a tumor suppressor and prognostic
marker in breast cancer. Cancer Sci. 2012; 103(12):2092–101. https://doi.org/10.1111/cas.12020
PMID: 22957844
8. Gu Z, Ding G, Liang K, Zhang H, Guo G, Zhang L, et al. TESTIN suppresses tumor growth and invasion
via manipulating cell cycle progression in endometrial carcinoma. Med Sci Monit. 2014; 20:980–7.
https://doi.org/10.12659/MSM.890544 PMID: 24929083
9. Li H, Huang K, Gao L, Wang L, Niu Y, Liu H, et al. TES inhibits colorectal cancer progression through
activation of p38. Oncotarget. 2014; 7(29):45819–36.
10. Weeks RJ, Ludgate JL, LeMe´e G, Morison IM. TESTIN Induces Rapid Death and Suppresses Prolifera-
tion in Childhood B Acute Lymphoblastic Leukaemia Cells. PLoS One. 2016; 11(3):e0151341. https://
doi.org/10.1371/journal.pone.0151341 PMID: 26985820
11. Coutts AS, MacKenzie E, Griffith E, Black DM. TES is a novel focal adhesion protein with a role in cell
spreading. J Cell Sci. 2003; 116(Pt 5):897–906. PMID: 12571287
Expanding the conformational model of testin
PLOS ONE | https://doi.org/10.1371/journal.pone.0177879 May 18, 2017 19 / 21
12. Griffith E, Coutts AS, Black DM. Characterisation of Chicken TES and Its Role in Cell Spreading and
Motility. Cell Motil Cytoskeleton. 2004; 57(3):133–42. https://doi.org/10.1002/cm.10162 PMID:
14743347
13. Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, et al. Adenoviral transduction of
TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.
Clin Cancer Res. 2005; 11(2 I):806–13.
14. Drusco A, Zanesi N, Roldo C, Trapasso F, Farber JL, Fong LY, et al. Knockout mice reveal a tumor sup-
pressor function for Testin. Proc Natl Acad Sci U S A. 2005; 102(31):10947–51. https://doi.org/10.1073/
pnas.0504934102 PMID: 16033868
15. Rotter B, Bournier O, Nicolas G, Dhermy D, Lecomte M-C. AlphaII-spectrin interacts with Tes and EVL,
two actin-binding proteins located at cell contacts. Biochem J. 2005; 388(Pt 2):631–8. https://doi.org/10.
1042/BJ20041502 PMID: 15656790
16. Hadzic E, Catillon M, Halavatyi A, Medves S, Van Troys M, Moes M, et al. Delineating the tes interaction
site in zyxin and studying cellular effects of its disruption. PLoS One. 2015; 10(10):1–27.
17. Oldenburg J, van der Krogt G, Twiss F, Bongaarts A, Habani Y, Slotman JA, et al. VASP, zyxin and
TES are tension-dependent members of Focal Adherens Junctions independent of the α-catenin-vincu-
lin module. Sci Rep. Nature Publishing Group; 2015; 5(October):17225.
18. Sala S, Van Troys M, Medves S, Catillon M, Timmerman E, Staes A, et al. Expanding the interactome
of TES by exploiting TES modules with different subcellular localizations. J Proteome Res. 2017;acs.
jproteome.7b00034.
19. Griffith E, Coutts AS, Black DM. RNAi knockdown of the focal adhesion protein TES reveals its role in
actin stress fibre organisation. Cell Motil Cytoskeleton. 2005; 60(3):140–52. https://doi.org/10.1002/cm.
20052 PMID: 15662727
20. Eyckerman S, Impens F, Van Quickelberghe E, Samyn N, Vandemoortele G, De Sutter D, et al. Intelli-
gent Mixing of Proteomes for Elimination of False Positives in Affinity Purification-Mass Spectrometry. J
Proteome Res. 2016; 15(10):3929–37. https://doi.org/10.1021/acs.jproteome.6b00517 PMID:
27640904
21. Pollard TD. A guide to simple and informative binding assays. Mol Biol Cell. 2010; 21:4061–7. https://
doi.org/10.1091/mbc.E10-08-0683 PMID: 21115850
22. Gubb D, Green C, Huen D, Coulson D, Johnson G, Tree D, et al. The balance between isoforms of the
Prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev. 1999;
13(17):2315–27. PMID: 10485852
23. Pistor S, Chakraborty T, Niebuhr K, Domann E, Wehland J. The ActA protein of Listeria monocytogenes
acts as a nucleator inducing reorganization of the actin cytoskeleton. EMBO J. 1994; 13(4):758–63.
PMID: 8112291
24. Fradelizi J, Noireaux V, Plastino J, Menichi B, Louvard D, Sykes C, et al. ActA and human zyxin harbour
Arp2/3-independent actin-polymerization activity. Nat Cell Biol. 2001; 3(8):699–707. https://doi.org/10.
1038/35087009 PMID: 11483954
25. Chinthalapudi K, Patil DN, Rangarajan ES, Rader C, Izard T. Lipid-directed vinculin dimerization. Bio-
chemistry. 2015; 54(17):2758–68. https://doi.org/10.1021/acs.biochem.5b00015 PMID: 25880222
26. Golji J, Mofrad MRK. The talin dimer structure orientation is mechanically regulated. Biophys J. Bio-
physical Society; 2014; 107(8):1802–9.
27. Thompson PM, Tolbert CE, Campbell SL. Vinculin and metavinculin: Oligomerization and interactions
with F-actin. FEBS Lett. Federation of European Biochemical Societies; 2013; 587(8):1220–9.
28. Ivetic A, Ridley AJ. Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunol-
ogy. 2004; 112(2):165–76. https://doi.org/10.1111/j.1365-2567.2004.01882.x PMID: 15147559
29. El Omari K, Hoosdally SJ, Tuladhar K, Karia D, Vyas P, Patient R, et al. Structure of the leukemia onco-
gene LMO2: Implications for the assembly of a hematopoietic transcription factor complex. Blood.
2011; 117(7):2146–56. https://doi.org/10.1182/blood-2010-07-293357 PMID: 21076045
30. Sweede M, Ankem G, Chutvirasakul B, Azurmendi HF, Chbeir S, Watkins J, et al. Structural and mem-
brane binding properties of the prickle PET domain. Biochemistry. 2008; 47(51):13524–36. https://doi.
org/10.1021/bi801037h PMID: 19053268
31. Zhong Y, Zhu J, Wang Y, Zhou J, Ren K, Ding X, et al. LIM domain protein TES changes its conforma-
tional states in different cellular compartments. Mol Cell Biochem. 2009; 320(1–2):85–92. https://doi.
org/10.1007/s11010-008-9901-7 PMID: 18696217
32. Wodak SJ, Malevanets A, MacKinnon SS. The Landscape of Intertwined Associations in Homooligo-
meric Proteins. Biophys J. Elsevier B.V.; 2015; 109(6):1067–100.
33. Gronenborn AM. Protein acrobatics-Dimerization via domain swapping. Curr Opin Struc Biol. 2010; 19
(1):39–49.
Expanding the conformational model of testin
PLOS ONE | https://doi.org/10.1371/journal.pone.0177879 May 18, 2017 20 / 21
34. Leyman S, Sidani M. Unbalancing the Phosphatidylinositol-4, 5-bisphosphate–Cofilin Interaction
Impairs Cell Steering. Mol Biol Cell. 2009; 20(21):4509–23. https://doi.org/10.1091/mbc.E09-02-0121
PMID: 19741095
35. Lambrechts A, Kwiatkowski A V., Lanier LM, Bear JE, Vandekerckhove J, Ampe C, et al. cAMP-depen-
dent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin
and SH3 domains. J Biol Chem. 2000; 275(46):36143–51. https://doi.org/10.1074/jbc.M006274200
PMID: 10945997
Expanding the conformational model of testin
PLOS ONE | https://doi.org/10.1371/journal.pone.0177879 May 18, 2017 21 / 21
